CRL · Charles River Laboratories International, Inc.
AI read · Neutral
The AI's read
That change is only in Baird's estimate, not in CRL's operations. The source calls it routine coverage and reports no change to the company's business or plans.
Baird's target rose by $1, but the source calls this routine coverage and reports no change to CRL's operations or plans. It does not change the company's outlook.
That change is only in Baird's estimate, not in CRL's operations. The source calls it routine coverage and reports no change to the company's business or plans.
Follow Charles River Laboratories International, Inc. (CRL) free. When we publish a story about it, you get the plain-English explanation as an alert.
Get alerts for CRL